Article Information
History
- November 4, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Matthew Plassmeyer1,
- Oral Alpan1,
- Michael J. Corley2,
- Kimberleigh Lillard1,
- Paige Coatney1,
- Tina Vaziri1,
- Suzan Michalsky1,
- Thomas A. Premeaux2,
- Alina P.S. Pang2,
- Zaheer Bukhari5,
- Stephen T. Yueng2,
- Teresa H Evering2,
- Gail Naughton3,
- Martin Latterich3,
- Philip Mudd4,
- Alfred Spada3,
- Nicole Rindone3,
- Denise Loizou3,
- Lishomwa C. Ndhlovu2,#,* and
- Raavi Gupta5,#,*
- 1Amerimmune, Fairfax VA
- 2Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, New York, NY
- 3Histogen, Inc, CA
- 4Department of Emergency Medicine, Washington University School of Medicine, Saint Louis, MO
- 5SUNY Downstate Health Sciences University, Brooklyn, New York
- ↵#Corresponding Author: Lishomwa C. Ndhlovu MD, PhD, Professor-Elect, Department of Medicine, Division of Infectious Diseases, Weill Cornell Medicine, 413E 69th St, New York, NY Email: lndhlovu{at}med.cornell.edu
Posted November 04, 2020.
Caspases in COVID-19 Disease and Sequela and the Therapeutic Potential of Caspase Inhibitors
